Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
The Journal of Biological Chemistry|June 10, 2010
The small G protein Rac1 activates phospholipase Cdelta1 through phospholipase Cbeta2Yuanjian Guo, Urszula Golebiewska, Stephen D'Amico, et al.Elife|April 4, 2024
STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancerStephen D'Amico, Varvara Kirillov, Oleksi Petrenko, et al.Iscience|February 3, 2025
Intratumor heterogeneity in KRAS signaling shapes treatment resistanceOleksi Petrenko, Varvara Kirillov, Stephen D'Amico, et al.Biorxiv : the Preprint Server for Biology|September 21, 2023
STAT3 is a genetic modifier of TGF-beta induced EMT in KRAS mutant pancreatic cancerStephen D'Amico, Varvara Kirillov, Oleksi Petrenko, et al.Journal of the American Society of Nephrology : JASN|November 13, 2023
Ablation of Long Noncoding RNA Hoxb3os Exacerbates Cystogenesis in Mouse Polycystic Kidney DiseaseIvan Weisser, Kara Eckberg, Stephen D'Amico, et al.Proceedings of the National Academy of Sciences of the United States of America|October 2, 2023
Oncogenic dependency plays a dominant role in the immune response to cancerJinyu Li, Stephen D'Amico, Varvara Kirillov, et al.Scientific Reports|January 8, 2026
Loss of Snhg5 disrupts cell-cycle regulation without altering cystogenesis in a mouse model of polycystic kidney diseaseStephen D'Amico, Ujala Dar, Kara Eckberg, et al.Genes & Development|August 24, 2018
STAT3 is a master regulator of epithelial identity and KRAS-driven tumorigenesisStephen D'Amico, Jiaqi Shi, Benjamin L Martin, et al.Plos One|March 2, 2021
IL-6 promotes MYC-induced B cell lymphomagenesis independent of STAT3Oleksi Petrenko, Jinyu Li, Velasco Cimica, et al.EMBO Reports|August 26, 2025
STAT3 sustains tumorigenicity following mutant KRAS ablationStephen D'Amico, Varvara Kirillov, Jingxuan Liu, et al.Pageof 2